PARP inhibitors – a new direction in the treatment of breast and ovarian cancerKarol Gawalski, Włodzimierz Sawicki, Magdalena Bizoń et al.|Ginekologia Onkologiczna/Current Gynecologic Oncology|2022Cited by 2